As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...